Hims House

By Jonathan Stern

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.

Image by Jonathan Stern

Category: Investing

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast
    

Subscribers: 1
Reviews: 0
Episodes: 41

Description

Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. himshouse.substack.com

Episode Date
Ep 41 - Peter Pitts on The Wild West of Compounded GLP-1s
Aug 14, 2025
Ep 40 - HIMS Q2 Earnings Recap
Aug 05, 2025
Ep 39 - Legendary Wall Street analyst David Maris on why Hims could be massive—and what could go wrong
Jul 22, 2025
Ep 38 - HIMS WEEK IN REVIEW: Bloomberg, WaPo, Canada, Blood Tests, Nighthawk, and 38% Short Interest 🤯
Jul 16, 2025
Ep 37 - Top Patent Attorney Explains Why Novo Nordisk Is UNLIKELY to Sue Hims
Jul 01, 2025
Ep 36 - Adam May: The Bear Case on HIMS, GLP-1s, Legal Risk, and the Collapse of the Novo Deal
Jun 23, 2025
Ep 35 - Hims x ZAVA: Deep Dive ft. European Healthcare Experts, Sekander Amini + Mads Christiansen
Jun 18, 2025
Ep 33 - Max Marchione: Superpower, Hims, and the future of AI-powered medicine
Jun 12, 2025
🚨 Ep 34 - HIMS ACQUIRES ZAVA, EXPANDS INTO EUROPE
Jun 03, 2025
Ep 32 - Antonio Linares Makes the Case for Hims as a 100x — From Here
May 29, 2025
Ep 31 - The Amit Episode: Pitching HIMS to a Long-Time Skeptic
May 21, 2025
Ep 30 - Mark Cuban on Cost Plus Drugs, Hims & Hers, and the Future of Healthcare
May 13, 2025
Ep 29 - HIMS Q1 2025 Earnings Recap
May 06, 2025
Ep 28 - WallStreetBets legend who made 100,000% on GameStop breaks down HIMS short squeeze setup
May 02, 2025
🚨 EMERGENCY POD: Ep 27 - Hims Inks Deal with Novo Nordisk To Sell Wegovy
Apr 29, 2025
Ep 26 - Martin Shkreli: The Case for Hims & Hers
Apr 28, 2025
Ep 25 - Raul Shah: Why HIMS Could Be A 100-Bagger
Apr 17, 2025
Ep 24 - Alex Beinfield, Blue Duck Capital: "Don't Miss the Forest for the Trees"
Apr 10, 2025
🚨 HIMS CEO ANDREW DUDUM JOINS THE PODCAST
Mar 27, 2025
🚨 EMERGENCY POD: Ep 22 - FDA Ends Semaglutide Shortage, Plus Q4 Earnings Preview (Feb 21, 2025)
Feb 21, 2025
Ep 21 - Super Bowl Ad Recap, Hot CPI, Short Interest Up AGAIN
Feb 14, 2025
Ep 20 - HIMS Super Bowl Ad, Short Squeeeeze Potential, and Testosterone (Jan 30, 2025)
Jan 30, 2025
Ep 19 - A Wall Street Analyst's $HIMS Bull Case (Jan 20, 2025)
Jan 20, 2025
Ep 18 - The Politics Episode: Trump, Elon, RFK, Makary, Greenland, and More (Jan 15, 2025)
Jan 15, 2025
Ep 17 - 2024 Year in Review Episode (Jan 6, 2025)
Jan 06, 2025
Ep 16 - FDA Ends Tirzepatide Shortage 🚨 ft. SPECIAL GUEST "BAYSIDE" (Dec 20, 2024)
Dec 20, 2024
Ep 15 - Meta Ad Crackdown, Ro-Lilly Partnership, American Diabetes Association, GLP-1s (Dec 13, 2024)
Dec 13, 2024
Ep 14 - FDA Delay, Tirzepatide Shortage, and New Meal Replacement Launch (Nov 25, 2024)
Nov 25, 2024
Ep 13 - Hims Nosedives 25% On Amazon Telehealth Announcement 🤯
Nov 14, 2024
Ep 12 - Hims & Hers Q3 Earnings Recap (Nov 6, 2024)
Nov 06, 2024
Ep 11 - Hims & Hers Q3 Earnings Preview (Oct 31, 2024)
Oct 31, 2024
Ep 10 - Healthcare in the UK (Oct 28, 2024)
Oct 28, 2024
Ep 9 - Hims’ Possible Next Drugs, 503B Hiring, GLP-1s, S&P 600 (Oct 21, 2024)
Oct 20, 2024
Ep 8 - Hims & Hers: Company Financials (Oct 14, 2024)
Oct 14, 2024
Ep 7 - Hims & Hers: The Telehealth Industry (Oct 10, 2024)
Oct 10, 2024
Ep 6 - Hims & Hers: Operations (Oct 7, 2024)
Oct 07, 2024
Ep 5 - Hims & Hers: The Customer Journey (Oct 3, 2024)
Oct 03, 2024
Ep 4 - Hims & Hers Product Deep Dive (Sep 30, 2024)
Sep 30, 2024
Ep 3 - The History of Hims & Hers (Sep 26, 2024)
Sep 26, 2024
Ep 2 - Hims & Hers’ Business Model (Sep 24, 2024)
Sep 24, 2024
Ep 1 - An Overview of Hims & Hers (Sep 19, 2024)
Sep 19, 2024